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Risk reduction by 
HPV-testing in women with 
premalignant cervical lesions
Studies of clinical management and 
observations on the immunological background
Development of cervical cancer is preceded by well-defi ned premalignant lesions. These lesions 
are classifi ed as cervical intraepithelial neoplasia (CIN). They are detectable by cervical cytology, 
which resulted in nationwide cervical cancer screening programs. Although these 
programs have led to a substantial reduction in mortality and morbidity of cervical cancer, 
there are many drawbacks including limited accuracy of cytology, unnecessary screening 
rounds, and over-treatment. 
A persistent infection with high risk Human Papillomavirus (hrHPV) is an obligatory condition 
for the development, maintenance and progression of CIN lesions. HPV testing, as an 
adjunct to cytology, will lead to a better selection of women at risk for development 
of cervical cancer and consequently to more effi cient cervical cancer screening 
strategies.
The fact that HPV testing can reduce the risk of detection failure in cervical 
screening is confi rmed in clinically validated settings in the studies described 
in this thesis. New guidelines and recommendations are formulated. 
